Qsam Biosciences Total Debt vs. Cash And Equivalents
| QSAMDelisted Stock | USD 4.49 0.05 1.13% |
For Qsam Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Qsam Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Qsam Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Qsam Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Qsam Biosciences over time as well as its relative position and ranking within its peers.
Qsam |
Qsam Biosciences Cash And Equivalents vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Qsam Biosciences's current stock value. Our valuation model uses many indicators to compare Qsam Biosciences value to that of its competitors to determine the firm's financial worth. Qsam Biosciences is rated below average in total debt category among its peers. It also is rated below average in cash and equivalents category among its peers creating about 57.25 of Cash And Equivalents per Total Debt. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Qsam Biosciences' earnings, one of the primary drivers of an investment's value.Qsam Total Debt vs. Competition
Qsam Biosciences is rated below average in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 175.6 Million. Qsam Biosciences adds roughly 7,500 in total debt claiming only tiny portion of equities under Health Care industry.
Qsam Cash And Equivalents vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Qsam Biosciences |
| = | 7.5 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Qsam Biosciences |
| = | 429.35 K |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Qsam Cash And Equivalents Comparison
Qsam Biosciences is currently under evaluation in cash and equivalents category among its peers.
Qsam Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Qsam Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Qsam Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Qsam Biosciences' change in net profit over the period of time. It can combine multiple indicators of Qsam Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas. Qsam Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Qsam Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Qsam Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Qsam Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Qsam Biosciences' important profitability drivers and their relationship over time.
Use Qsam Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qsam Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qsam Biosciences will appreciate offsetting losses from the drop in the long position's value.Qsam Biosciences Pair Trading
Qsam Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Qsam Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qsam Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qsam Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qsam Biosciences to buy it.
The correlation of Qsam Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qsam Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qsam Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qsam Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Qsam Biosciences position
In addition to having Qsam Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Biotech Thematic Idea Now
Biotech
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |